CD274 and non-small cell lung carcinoma: A study analyzing biopsies from 123 NSCLC patients reported 56 EGFR mutant and 29 KRAS mutant tumors, with a significant correlation of EGFR mutation with PD-L1 expression, and KRAS mutation with PD-1 expression.